Symetis

Medical Devices & EquipmentSeries AEcublens, Switzerlandsymetis.com

Latest round

Series A

Last raised

Nov 2004

Total raised

$9.6M

Investors

5

About Symetis

Symetis SA is a medical technology firm specializing in the development of innovative heart valve solutions for transcatheter aortic valve implantation (TAVI) procedures.Founded in 2001 in Ecublens, Switzerland, Symetis SA focuses on creating medical devices for heart valve treatments. The company was acquired by Boston Scientific in March 2017 for USD 435 mn, and the deal was completed in May 2017. The acquisition allowed Boston Scientific to expand its portfolio in cardiac care.Symetis SA offers advanced heart valve devices specifically designed for transcatheter aortic valve implantation (TAVI). Their flagship products include the Acurate neo™ valve, which is engineered for precise placement and optimal hemodynamic performance.Symetis SA generates revenue through the direct sale of its heart valve devices to healthcare institutions. Its pricing model includes per-unit sales as well as bulk purchasing agreements with hospitals. Target markets for expansion include North America and key European nations, with planned launches of new products scheduled for late 2024.

Who invested in Symetis

5 investors across 1 round

See all investors in Symetis

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Nov 13, 2004

    Amount

    $9.6M

    Investors

    Locked

Questions about Symetis

Who invested in Symetis?

Symetis has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Symetis raised?

Symetis has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Symetis last raise money?

Symetis's most recent round on record is a Series A, in Nov 2004.

What does Symetis do?

Symetis SA is a medical technology firm specializing in the development of innovative heart valve solutions for transcatheter aortic valve implantation (TAVI) procedures.

Where is Symetis headquartered?

Symetis is headquartered in Ecublens, Switzerland.

Which VCs invest in companies like Symetis?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back medical devices & equipment companies at Symetis's stage. Their profiles are linked below.

Raising like Symetis? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.